TCRT Stock Summary and Trading Ideas (Alaunos Therapeutics | NASDAQ:TCRT)

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Alaunos Therapeutics trades on the NASDAQ stock market under the symbol TCRT.

As of October 13, 2026, TCRT stock price climbed to $3.03 with 169,480,046 million shares trading.

TCRT has a beta of 0.14, meaning it tends to be less sensitive to market movements. TCRT has a correlation of 0.00 to the broad based SPY ETF.

TCRT has a market cap of $7.70 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, TCRT traded as high as $32.85 and as low as $.72.

The top ETF exchange traded funds that TCRT belongs to (by Net Assets): VXF.

TCRT has underperformed the market in the last year with a return of -12.9%, while SPY returned +18.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TCRT shares. However, TCRT has outperformed the market in the last 3 month and 2 week periods, returning +47.8% and +197.1%, while SPY returned +4.1% and +1.8%, respectively. This indicates TCRT has been having a stronger performance recently.

TCRT support price is $.96 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TCRT shares will trade within this expected range on the day.